Stay updated with breaking news from Extended Release Tablets. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Mumbai, Naples, April 20, 2024: Global pharma major Lupin Limited today announced the launch of Mirabegron Extended-Release Tablets, 25 mg, in the United States, after having received...
Pharma major Lupin Limited announced on Monday that it has launched Mirabegron extended-release tablets, 25 mg, in the United States market, after having received approval from the United States Food and Drug Administration (U.S. ...
Zydus Lifesciences Limited announces the launch of Mirabegron Extended-Release Tablets, 25 mg in the US market. The company had earlier received final approval from the United States Food and Drug...
Acorda Therapeutics, Inc. announced that Nasdaq Stock Market today notified the Company that it will suspend trading in and delist the Company's common stock, effective with the opening of business...
Acorda Therapeutics, Inc. today announced that it will no longer hold its fourth quarter and year end 2023 earnings conference call originally scheduled for Monday, April 1 at 4:30 p.m. ET. The...